N-Ethyl-N-methylcarbamoyl Chloride: High-Purity Pharmaceutical Intermediate Supplier in China

Discover the critical role of N-Ethyl-N-methylcarbamoyl Chloride (CAS: 42252-34-6) in pharmaceutical synthesis. As a leading manufacturer and supplier in China, we provide high-purity intermediates essential for drugs like Rivastigmine, offering reliability and quality for your research and production needs. Get a quote today!

Get a Quote & Sample

Key Advantages of Our Pharmaceutical Intermediates

Exceptional Purity and Consistency

Our N-Ethyl-N-methylcarbamoyl Chloride boasts a purity of ≥98%, ensuring reliable performance in complex pharmaceutical syntheses and consistent batch-to-batch quality for your production.

Critical Role in Neurodegenerative Disease Treatment

As a key intermediate for Rivastigmine, our product directly contributes to the manufacturing of essential medications for Alzheimer's and Parkinson's patients, highlighting its importance.

Secure Supply Chain from China

Leverage our robust manufacturing infrastructure in China to secure a stable and timely supply of this crucial pharmaceutical intermediate. We are a trusted manufacturer and supplier.

Applications in Pharmaceutical Synthesis

Rivastigmine Tartrate Synthesis

This compound is a crucial building block in the synthesis of Rivastigmine Tartrate (CAS: 129101-54-8), a key pharmaceutical ingredient used in treating Alzheimer's and Parkinson's disease.

Active Pharmaceutical Ingredient (API) Manufacturing

Its high purity and specific chemical structure make it an indispensable intermediate for the production of various Active Pharmaceutical Ingredients (APIs), ensuring efficacy and safety.

Cholinesterase Inhibitor Development

As a precursor for cholinesterase inhibitors, it plays a vital role in developing drugs that manage cognitive decline by regulating neurotransmitter levels.

Research and Development

Essential for R&D projects in medicinal chemistry, enabling the exploration and synthesis of novel therapeutic compounds and drug candidates.